Skip to content
Disfunción Eréctil

Tratamientos de Disfunción Eréctil

Explore los tratamientos de disfunción eréctil disponibles. Todos incluyen una revisión por un médico independiente de la UE, medicamentos genuinos de farmacias autorizadas y entrega exprés discreta.

2026-04-12 Tratamientos

Interested in Disfunción Eréctil?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Erectile dysfunction treatments in Europe

Erectile dysfunction (ED) — defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance — is one of the most prevalent male health conditions in Europe. Clinical studies estimate that ED affects approximately 19–52% of men between the ages of 40 and 70, with prevalence increasing markedly with age. Despite this, it remains significantly undertreated, with many men not seeking help due to embarrassment or a lack of accessible, confidential services.

ED can have both psychological and physiological causes, and in most cases the two are interrelated. Physiological factors include cardiovascular disease, diabetes, hypertension, hyperlipidaemia, hormonal imbalances, and neurological conditions. Lifestyle factors — including smoking, excessive alcohol consumption, obesity, and physical inactivity — are also established risk factors. Psychological contributors include performance anxiety, relationship difficulties, depression, and stress.

Critically, erectile dysfunction is recognised by European cardiovascular guidelines as a potential early marker of atherosclerosis and future cardiac events. Men presenting with new-onset ED should be evaluated for cardiovascular risk factors by a qualified clinician.

The first-line pharmacological treatment for ED is the class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. These medications enhance the natural physiological pathway that produces an erection in response to sexual stimulation — they do not produce erections independently and are not effective without arousal. Four PDE5 inhibitors are currently EMA-approved: sildenafil, tadalafil, vardenafil, and avanafil.

Tratamientos disponibles

The following EMA-approved prescription medications are available for erectile dysfunction a través de médicos registrados en la UE. Esta comparación se proporciona únicamente con fines informativos.

MedicationActive IngredientOnsetDurationNotes
SildenafilSildenafil citrate30–60 min4–6 hoursGeneric available; original Viagra
TadalafilTadalafil30–60 minUp to 36 hoursAlso available as daily 5 mg dose
VardenafilVardenafil HCl25–60 min4–6 hoursAlso available as orodispersible tablet
AvanafilAvanafil15–30 min6–12 hoursFastest onset; fewer food/alcohol interactions

Distinciones clave:

  • Sildenafil: The most widely prescribed PDE5 inhibitor globally. Generic versions are available in most EU countries, making it typically the most cost-accessible option.
  • Tadalafil: The longest duration of action, earning it the informal name “the weekend pill.” The daily low-dose formulation (5 mg) allows spontaneous sexual activity without planning around timing.
  • Vardenafil: Similar efficacy profile to sildenafil. The orodispersible (dissolving tablet) formulation provides a discreet and convenient alternative to standard tablets.
  • Avanafil: The newest approved PDE5 inhibitor. Its faster onset and more selective mechanism may result in fewer side effects in some men, though individual response varies.

How to get erectile dysfunction treatment online

Prescrivia opera como intermediario tecnológico. No prescribimos medicamentos, no empleamos médicos ni vendemos medicamentos. Nuestra plataforma conecta a pacientes de toda Europa con médicos independientes registrados en la UE y farmacias autorizadas.

El proceso:

  1. Complete a health assessment — Answer a structured set of medical questions covering the nature and duration of your ED, cardiovascular health, diabetes status, current medications (particularly nitrates or alpha-blockers), blood pressure, and lifestyle factors.

  2. Revisión por médico independiente — An independent EU-registered doctor reviews your assessment. If a PDE5 inhibitor is clinically appropriate, the doctor may issue a prescription. If contraindications are identified, the doctor will explain and may suggest in-person follow-up.

  3. Pharmacy fulfilment — If a prescription is issued, it is passed to a licensed EU pharmacy partner. Medication is dispensed and delivered discreetly to your address.

Importante: Prescrivia does not guarantee that a prescription will be issued. Prescribing decisions are made entirely by independent medical professionals.

Cómo nos comparamos

A través de PrescriviaConsulta presencial con médico
DisponibilidadEvaluación en línea 24/7Sujeto a disponibilidad de cita
Tiempo de esperaEvaluación revisada en horasDe días a semanas según la ubicación
Desplazamiento necesarioNoYes
ConfidentialityFull RGPD-compliant data protectionStandard clinical confidentiality
Decisión de prescripciónRealizada por un médico independiente registrado en la UERealizada por su médico de cabecera
CostePrecios transparentes mostrados de antemanoVaría según el país y el sistema sanitario

Nota: ED associated with chest pain, severe cardiovascular disease, recent heart attack or stroke, or other complex comorbidities requires in-person specialist evaluation before any pharmacological treatment is considered. Prescrivia’s platform is designed for adults whose ED profile is suitable for remote assessment.

Fuentes

La información médica de esta página se basa en las siguientes fuentes:

  • European Medicines Agency (EMA). Viagra/sildenafil — Summary of Product Characteristics. Disponible en: ema.europa.eu
  • Feldman HA, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology. 1994;151(1):54-61.
  • Vlachopoulos CV, et al. Erectile dysfunction as a cardiovascular risk factor. European Heart Journal. 2013.

Este contenido se revisa periódicamente para reflejar las directrices clínicas actualizadas. Se proporciona únicamente con fines informativos y no constituye asesoramiento médico. Consulte siempre a un profesional sanitario cualificado para obtener asesoramiento relevante para sus circunstancias de salud individuales.

Frequently asked questions

Can I get erectile dysfunction medication online in Europe?
Yes. Prescrivia connects patients with independent EU-registered doctors who can review your health profile and, where clinically appropriate, issue a prescription for erectile dysfunction medication. The entire process is completed online with full confidentiality.
What is the difference between sildenafil and tadalafil?
Both are PDE5 inhibitors that work by the same mechanism, but they differ primarily in duration of action. Sildenafil works for approximately 4–6 hours and is typically taken 30–60 minutes before activity. Tadalafil lasts up to 36 hours and is also available as a once-daily low-dose formulation for spontaneous use.
Are there newer ED medications beyond sildenafil?
Yes. Vardenafil and avanafil are also EMA-approved PDE5 inhibitors. Avanafil has a faster onset than sildenafil — effects can begin within 15 minutes for some men. The most appropriate choice depends on individual health factors and preference, which the reviewing doctor will assess.
Is it safe to take ED medication with other medications?
PDE5 inhibitors are contraindicated with nitrate medications (commonly used for chest pain and heart conditions), as the combination can cause a dangerous drop in blood pressure. Other drug interactions also exist. This is why a medical assessment is required before any prescription is issued.
Can erectile dysfunction indicate a more serious health problem?
ED can be an early warning sign of cardiovascular disease, diabetes, hypertension, or hormonal imbalances. The health assessment includes questions to screen for relevant risk factors. If warranted, the reviewing doctor may recommend further investigation before or alongside treatment.
Prescrivia es únicamente una plataforma intermediaria. No prestamos servicios médicos, no prescribimos tratamientos ni dispensamos medicamentos. Todas las decisiones médicas son tomadas por médicos independientes registrados en la UE. Todos los medicamentos son dispensados por farmacias autorizadas de la UE. Esta plataforma facilita la conexión entre pacientes y profesionales sanitarios.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

¿Listo para empezar?

Complete una evaluación de salud confidencial en unos 3 minutos.